- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 7th, 2007
That's why I'm wading into the fray. Nanotechnology is still driven by hundreds and hundreds of smart, innovative Little Guys. If America is going to continue to a global nanotechnology leader, our laws need to protect the ones who make it happen. As you can tell by the title of this column, I'm more than a little concerned. There are so many "ifs, ands, and buts" in the proposed law, I'm wondering if a patent is the best way to protect your intellectual property anymore. At my company we've long relied on trade secrets as an alternative to patents for protecting our intellectual property. And we may start doing it more.
But I'm getting ahead of myself. Let's lay out the provisions of the legislation. The first element would replace the current system that awards patents on a "first to invent" basis with a "first to file" system. This is how all foreign patents are granted, and most big companies operating in the international arena operate this way anyway. The change alleviates the cumbersome process of the Patent Office determining the invention date when there's a dispute, so it could streamline the patent process. The downside? Decisions made by a postmark date don't favor small companies that don't have a team of patent lawyers to handle this complicated process.
|Related News Press|
Graphene leans on glass to advance electronics: Scientists' use of common glass to optimize graphene's electronic properties could improve technologies from flat screens to solar cells February 12th, 2016
A metal that behaves like water: Researchers describe new behaviors of graphene February 12th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016
Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016